The new test specifically targets the XBB.1.5 Omicron variant and will help researchers closely track the virus's lineage and provide insights into the epidemiology and impact it has on public health, the company added.

The XBB.1.5 variant is prevalent in the United States and is quickly spreading to other countries, Roche said.

"Being able to differentiate emerging variants and understand their similarities and mutations provides a basis for experts to make predictions about their spread and respond with appropriate treatment strategies," Roche said.

(Reporting by John Revill; Editing by Noele Illien)